FDA Inspection 951219 — Livzon New North River Pharmaceutical Co., Ltd.
The FDA completed an inspection of Livzon New North River Pharmaceutical Co., Ltd. on November 6, 2015 in Qingyuan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 6, 2015
- Fiscal Year
- 2016
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Qingyuan (China)